Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000541712 | SCV000657238 | likely benign | Bethlem myopathy 1A | 2024-08-08 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003144370 | SCV003834581 | uncertain significance | not provided | 2020-04-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004701649 | SCV005202951 | uncertain significance | not specified | 2024-07-23 | criteria provided, single submitter | clinical testing | Variant summary: COL6A3 c.1061G>A (p.Ser354Asn) results in a conservative amino acid change located in the von Willebrand factor, type A (IPR002035) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 250956 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. To our knowledge, no occurrence of c.1061G>A in individuals affected with Ullrich Congenital Muscular Dystrophy 1 and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 476499). Based on the evidence outlined above, the variant was classified as uncertain significance. |